Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.23 USD | +2.29% | -15.05% | -9.35% |
Mar. 27 | HC Wainwright Adjusts BioAtla's Price Target to $7 From $10, Maintains Buy Rating | MT |
Mar. 26 | Transcript : BioAtla, Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
Business Summary
Number of employees: 65
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jay Short
CEO | Chief Executive Officer | 66 | 07-02-28 |
Founder | 59 | 07-02-28 | |
Richard Waldron
DFI | Director of Finance/CFO | 70 | 10-12-31 |
Gerhard Frey
CTO | Chief Tech/Sci/R&D Officer | - | 07-03-31 |
Cathy Chang
CTO | Chief Tech/Sci/R&D Officer | - | - |
Eric Sievers
CTO | Chief Tech/Sci/R&D Officer | 60 | 19-05-31 |
Scott Smith
BRD | Director/Board Member | 61 | 18-09-09 |
Susie Melody
HRO | Human Resources Officer | - | - |
Comptroller/Controller/Auditor | 48 | 15-10-31 | |
Mike Melnick
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mary Gray
BRD | Director/Board Member | 71 | 20-11-30 |
Jay Short
CEO | Chief Executive Officer | 66 | 07-02-28 |
Director/Board Member | 76 | 15-12-31 | |
Edward Williams
BRD | Director/Board Member | 68 | 21-12-15 |
Sylvia Mcbrinn
BRD | Director/Board Member | 71 | 21-06-14 |
Scott Smith
BRD | Director/Board Member | 61 | 18-09-09 |
Susan Moran
BRD | Director/Board Member | 54 | 20-11-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 48,096,717 | 43,356,946 ( 90.15 %) | 0 | 90.15 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.72% | 105M | |
+3.14% | 42.11B | |
+48.83% | 40.08B | |
+8.44% | 40B | |
-10.82% | 26.87B | |
+8.21% | 24.58B | |
-22.98% | 18.44B | |
+1.48% | 11.94B | |
+33.21% | 11.66B | |
+7.01% | 11.01B |
- Stock Market
- Equities
- BCAB Stock
- Company BioAtla, Inc.